An enterprise owned by Elon Musk prepares itself to grow the first stroke in Canada

The Canadian University Health Network (UHN) has announced that Western Storonto Hospital will become the first website outside the United States in which a device was developed by “neuralink” attached to Elon Musk. “We are very proud to be at the forefront of this research progress in the field of neurosurgery,” Kevin Smith said. He also pointed out that the network will be the ‘first and exclusive website’ of the experience in Canada, without specifying the start date. On Wednesday, “Neuralink” confirmed that it approves the Canadian regulatory authorities to launch clinical experiments for their slide in Canada. The company wrote on the “X” platform, which is also attached to a mask: “The Canadian Health Authority has agreed to start our first clinical experience in Canada. The registration door is now open.” “Neuralink” added that it was looking for patients with four -fold paralysis caused by atrophic lateral sclerosis, or a spinal cord injury. The Canadian Health Authority did not immediately comment. Over the past few months, “neuralink” patients in the United States, the United Kingdom and Canada have recruited through registration links on its website. There are other companies in this area, such as “Synchron Inc”, which have also been recruited to perform future experiments. The first product of “neuralink” is aimed at enabling patients to control external devices, such as computers, using their ideas. The company also develops treatments for other cases such as blindness, but this project is still in the early stage. “Neuralink” can work with healthy patients to improve functions such as improving memory in the distant future. Earlier this year, the first “neuralink” human device was planted for a patient named Noland ARBU at the Baro Institute or Neurology in Phoenix.